1. Home
  2. EBON vs LNAI Comparison

EBON vs LNAI Comparison

Compare EBON & LNAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ebang International Holdings Inc.

EBON

Ebang International Holdings Inc.

HOLD

Current Price

$3.50

Market Cap

21.4M

Sector

Technology

ML Signal

HOLD

Logo Lunai Bioworks Inc. Common Stock

LNAI

Lunai Bioworks Inc. Common Stock

N/A

Current Price

$1.26

Market Cap

23.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EBON
LNAI
Founded
2010
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.4M
23.9M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
EBON
LNAI
Price
$3.50
$1.26
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.3K
11.7M
Earning Date
08-15-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,337,066.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
104.28
N/A
52 Week Low
$3.00
$0.81
52 Week High
$9.61
$21.00

Technical Indicators

Market Signals
Indicator
EBON
LNAI
Relative Strength Index (RSI) 40.08 N/A
Support Level $3.37 N/A
Resistance Level $3.70 N/A
Average True Range (ATR) 0.25 0.00
MACD 0.00 0.00
Stochastic Oscillator 20.84 0.00

Price Performance

Historical Comparison
EBON
LNAI

About EBON Ebang International Holdings Inc.

Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services and rental services. Its geographic regions are Mainland China, and Australia.

About LNAI Lunai Bioworks Inc. Common Stock

Lunai Bioworks Inc is a biopharmaceutical company. Through its subsidiaries, it is mainly focused on developing allogeneic cell and gene therapies to promote stronger immune system responses, potentially for long-term or life-long cancer remission in some of the deadliest cancers. The group is engaged in the development of RENB-DC11 and RENB-DC20 (potential cell therapeutic vaccine candidates for different types of cancer); a proprietary AI platform that analyzes genetics to provide earlier and more accurate cancer diagnosis; and machine learning pipelines that harmonize and analyze complex, heterogeneous datasets to uncover clinically actionable insights. The group's reportable segments are: RENB, BioSymetrics, and RENC. Geographically, it operates in the United States and Netherlands.

Share on Social Networks: